表紙:精密癌診断検査市場:2024-2034年
市場調査レポート
商品コード
1413736

精密癌診断検査市場:2024-2034年

Precision Cancer Diagnostic Test Market Report 2024-2034

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 370 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=204.74円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

精密癌診断検査市場:2024-2034年
出版日: 2024年01月17日
発行: Visiongain Reports Ltd.
ページ情報: 英文 370 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の精密癌診断検査の市場規模は、2034年にかけて16.1%のCAGRで成長すると予測されています。

癌診断におけるリキッドバイオプシーの採用の増加により、市場競争は著しく激化しており、この領域に積極的に参入している企業は臨床的進歩の重要な推進役とみなされています。循環腫瘍DNAやその他のマーカーに注目した非侵襲的なリキッドバイオプシーの開発が進んでおり、リアルタイムのモニタリングや早期発見を可能にすることで、癌診断を一変させることが期待されています。

一方で、精密癌診断検査は、次世代シーケンシング (NGS) や質量分析などの高度な技術を利用しますが、これらは高コストを伴う可能性があり、特に資源が乏しい地域では、利用しやすさに課題をもたらします。精密癌診断に関連する高額な費用が市場成長の妨げとなり、これらの高度な診断ツールの患者による利用が制限される可能性があります。より正確な診断や個別化された治療計画など、精密癌診断が提供する大きな利点にもかかわらず、これらの検査に関連する金銭的影響は、医療システムと患者の双方にとって困難な課題となっています。

当レポートでは、世界の精密癌診断検査の市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 課題
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • PEST分析

第4章 精密癌診断検査市場の分析:製品・サービス別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 製品
  • サービス
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第5章 精密癌診断検査市場の分析:検査タイプ別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 癌画像処理
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別
    • コンピュータ断層撮影
    • 磁気共鳴画像
    • デジタルおよびアナログマンモグラフィー
    • 陽電子放出断層撮影
    • デジタル乳房トモシンセシス
    • 乳房分子イメージング
    • その他
  • 分子癌検査
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別
    • ポリメラーゼ連鎖反応 (PCR)
    • 次世代シーケンス (NGS)
    • リキッドバイオプシー
    • 免疫組織化学 (IHC)
    • 蛍光In situハイブリダイゼーション (FISH)
    • その他
  • 腫瘍マーカー免疫測定法
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別
  • POC結腸癌検査
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第6章 精密癌診断検査市場の分析:用途別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 乳癌
  • 肺癌
  • 結腸直腸癌
  • 黒色腫
  • 膵臓癌
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第7章 精密癌診断検査市場の分析:生検法別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • リキッドバイオプシー
  • 組織生検
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第8章 精密癌診断検査市場の分析:エンドユーザー別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 診断研究所
  • 病院
  • 癌センター・クリニック
  • 研究機関
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第9章 精密癌診断検査市場の分析:地域別

  • 主要調査結果
  • 市場規模の推移・予測

第10章 北米の精密癌診断検査市場の分析

第11章 欧州の精密癌診断検査市場の分析

第12章 アジアの精密癌診断検査市場の分析

第13章 ラテンアメリカの精密癌診断検査市場の分析

第14章 中東・アフリカの精密癌診断検査市場の分析

第15章 企業プロファイル

  • 市場シェア分析
  • 戦略的展望
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Abbott
  • QIAGEN N.V.
  • Thermo Fisher Scientific
  • bioMerieux SA
  • Siemens Healthineers
  • Bayer AG
  • Myriad Genetics, Inc.
  • Agilent Technologies, Inc.

第16章 総論・推奨事項

  • Visiongainによる総論
  • 参入企業への推奨事項
図表

List of Tables

  • Table 1 Precision Cancer Diagnostic Test Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
  • Table 2 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 7 Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 8 Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 9 Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 10 Cancer Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 11 Computed Tomography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 12 Magnetic Resonance Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 13 Digital & Analog Mammography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 14 Positron Emission Tomography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 15 Digital Breast Tomosynthesis Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 16 Molecular Breast Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 17 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 18 Molecular Cancer Testing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Polymerase Chain Reaction (PCR) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 20 Next-Generation Sequencing (NGS) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 21 Liquid Biopsies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 22 Immunohistochemistry (IHC) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 23 Fluorescence In Situ Hybridization (FISH) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 24 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 25 Tumour Marker Immunoassays Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 26 POC Colon Cancer Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 27 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 28 Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 29 Breast Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 30 Lung Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 31 Colorectal Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 32 Melanoma Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 33 Pancreatic Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 34 Other Cancers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 35 Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 36 Liquid Biopsy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 37 Tissue Biopsy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 38 Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 39 Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 40 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 41 Cancer Centers and Clinics Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 42 Research Institutions Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 43 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 44 North America Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 45 North America Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 46 North America Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 47 North America Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 48 North America Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 49 North America Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 50 North America Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 51 North America Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 52 U.S. Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 53 Canada Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 54 Europe Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 55 Europe Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 56 Europe Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 57 Europe Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 58 Europe Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 Europe Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 60 Europe Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 61 Europe Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 62 Germany Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 63 UK Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 64 France Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 65 Italy Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 66 Spain Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 67 Russia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 68 Rest of Europe Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 69 Asia Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 70 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 71 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 72 Asia Pacific Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 73 Asia Pacific Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 74 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 75 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 76 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 77 Japan Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 78 China Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 79 India Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 80 Australia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 81 South Korea Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 82 Rest of Asia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 83 Latin America Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 84 Latin America Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 85 Latin America Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 86 Latin America Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 87 Latin America Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 88 Latin America Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 89 Latin America Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 90 Latin America Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 91 Brazil Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 92 Mexico Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 93 Argentina Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 94 Rest of Latin America Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 95 MEA Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 96 MEA Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 97 MEA Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 98 MEA Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 99 MEA Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 100 MEA Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 101 MEA Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 102 MEA Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 103 GCC Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
  • Table 104 South Africa Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 105 Rest of MEA Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 106 Strategic Outlook
  • Table 107 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 F. Hoffmann-La Roche Ltd: Product Benchmarking
  • Table 109 F. Hoffmann-La Roche Ltd: Strategic Outlook
  • Table 110 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Illumina, Inc.: Product Benchmarking
  • Table 112 Illumina, Inc.: Strategic Outlook
  • Table 113 Abbott.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 114 Abbott: Product Benchmarking
  • Table 115 Abbott.: Strategic Outlook
  • Table 116 QIAGEN N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 Qiagen N.V.: Product Benchmarking
  • Table 118 Qiagen N.V.: Strategic Outlook
  • Table 119 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 120 Thermo Fisher Scientific: Product Benchmarking
  • Table 121 Thermo Fisher Scientific: Strategic Outlook
  • Table 122 bioMerieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 123 BioMerieux SA: Product Benchmarking
  • Table 124 Siemens Healthineers: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 125 Canon Medical Systems Corporation: Product Benchmarking
  • Table 126 Siemens: Strategic Outlook
  • Table 127 Bayer AG.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 128 Bayer AG: Product Benchmarking
  • Table 129 Bayer AG: Strategic Outlook
  • Table 130 Myriad Genetics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 131 Myriad Genetics, Inc: Product Benchmarking
  • Table 132 Myriad Genetics: Strategic Outlook
  • Table 133 Agilent Technologies, Inc..: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 134 Agilent Technologies, Inc.: Product Benchmarking
  • Table 135 Agilent Technologies, Inc.: Strategic Outlook

List of Figures

  • Figure 1 Precision Cancer Diagnostic Test Market Segmentation
  • Figure 2 Precision Cancer Diagnostic Test Market by Products & Services: Market Attractiveness Index
  • Figure 3 Precision Cancer Diagnostic Test Market by Test Type: Market Attractiveness Index
  • Figure 4 Precision Cancer Diagnostic Test Market by Application: Market Attractiveness Index
  • Figure 5 Precision Cancer Diagnostic Test Market by Biopsy Method: Market Attractiveness Index
  • Figure 6 Precision Cancer Diagnostic Test Market by End-user: Market Attractiveness Index
  • Figure 7 Precision Cancer Diagnostic Test Market Attractiveness Index by Region
  • Figure 8 Precision Cancer Diagnostic Test Market: Market Dynamics
  • Figure 9 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 10 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 11 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 12 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 13 Precision Cancer Diagnostic Test Market: Porter's Five Forces Analysis
  • Figure 14 Precision Cancer Diagnostic Test Market: PEST Analysis
  • Figure 15 Precision Cancer Diagnostic Test Market by Products & Services: Market Attractiveness Index
  • Figure 16 Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
  • Figure 17 Precision Cancer Diagnostic Test Share Forecast by Products & Services, 2024, 2029, 2034 (%)
  • Figure 18 Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 19 Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 20 Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 21 Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 22 Precision Cancer Diagnostic Test Market by Test Type: Market Attractiveness Index
  • Figure 23 Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
  • Figure 24 Precision Cancer Diagnostic Test Share Forecast by Test Type, 2024, 2029, 2034 (%)
  • Figure 25 Cancer Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 26 Cancer Imaging Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 27 Computed Tomography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 28 Computed Tomography Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 29 Magnetic Resonance Imaging (MRI) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 30 Magnetic Resonance Imaging Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 31 Digital & Analog Mammography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 32 Digital & Analog Mammography Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 33 Positron Emission Tomography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 34 Positron Emission Tomography Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 35 Digital Breast Tomosynthesis Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 36 Digital Breast Tomosynthesis Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 37 Molecular Breast Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 38 Molecular Breast Imaging Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 39 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 40 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 41 Molecular Cancer Testing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 42 Molecular Cancer Testing Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 43 Polymerase Chain Reaction (PCR) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 44 Polymerase Chain Reaction (PCR) Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 45 Next-Generation Sequencing (NGS) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 46 Next-Generation Sequencing (NGS) Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 47 Liquid Biopsies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 48 Liquid Biopsies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 49 Immunohistochemistry (IHC) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 50 Immunohistochemistry (IHC) Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 51 Fluorescence In Situ Hybridization (FISH) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 52 Fluorescence In Situ Hybridization (FISH) Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 53 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 54 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 55 Tumour Marker Immunoassays Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 56 Tumour Marker Immunoassays Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 57 POC Colon Cancer Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 58 POC Colon Cancer Tests Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 59 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 60 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 61 Precision Cancer Diagnostic Test Market by Application: Market Attractiveness Index
  • Figure 62 Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 63 Precision Cancer Diagnostic Test Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 64 Breast Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 65 Breast Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 66 Lung Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 67 Lung Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 68 Colorectal Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 69 Colorectal Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 70 Melanoma Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 71 Melanoma Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 72 Pancreatic Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 73 Pancreatic Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 74 Other Cancers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 75 Other Cancers Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 76 Precision Cancer Diagnostic Test Market by Biopsy Method: Market Attractiveness Index
  • Figure 77 Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
  • Figure 78 Precision Cancer Diagnostic Test Share Forecast by Biopsy Method, 2024, 2029, 2034 (%)
  • Figure 79 Liquid Biopsy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 80 Liquid Biopsy Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 81 Tissue Biopsy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 82 Tissue Biopsy Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 83 Precision Cancer Diagnostic Test Market by End-user: Market Attractiveness Index
  • Figure 84 Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 85 Precision Cancer Diagnostic Test Share Forecast by End-user, 2024, 2029, 2034 (%)
  • Figure 86 Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 87 Diagnostic Laboratories Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 88 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 89 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 90 Cancer Centers and Clinics Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 91 Cancer Centers and Clinics Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 92 Research Institutions Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 93 Research Institutions Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 94 Precision Cancer Diagnostic Test Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
  • Figure 95 Precision Cancer Diagnostic Test Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 96 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 97 North America Precision Cancer Diagnostic Test Market Attractiveness Index
  • Figure 98 North America Precision Cancer Diagnostic Test Market by Region, 2024, 2029 & 2034 (US$Million)
  • Figure 99 North America Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 100 North America Precision Cancer Diagnostic Test Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 101 North America Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
  • Figure 102 North America Precision Cancer Diagnostic Test Market Share Forecast by Products & Services, 2024 & 2034 (%)
  • Figure 103 North America Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
  • Figure 104 North America Precision Cancer Diagnostic Test Market Share Forecast by Test Type, 2024 & 2034 (%)
  • Figure 105 North America Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 106 North America Cancer Imaging Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 107 North America Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 108 North America Molecular Cancer Testing Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 109 North America Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 110 North America Precision Cancer Diagnostic Test Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 111 North America Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
  • Figure 112 North America Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method, 2024 & 2034 (%)
  • Figure 113 North America Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 114 North America Precision Cancer Diagnostic Test Market Share Forecast by End-user, 2024 & 2034 (%)
  • Figure 115 U.S. Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 116 Canada Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 117 Europe Precision Cancer Diagnostic Test Market Attractiveness Index
  • Figure 118 Europe Precision Cancer Diagnostic Test Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 119 Europe Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 120 Europe Precision Cancer Diagnostic Test Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 121 Europe Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
  • Figure 122 Europe Precision Cancer Diagnostic Test Market Share Forecast by Products & Services, 2024 & 2034 (%)
  • Figure 123 Europe Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
  • Figure 124 Europe Precision Cancer Diagnostic Test Market Share Forecast by Test Type, 2024 & 2034 (%)
  • Figure 125 Europe Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 126 Europe Cancer Imaging Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 127 Europe Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 128 Europe Molecular Cancer Testing Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 129 Europe Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 130 Europe Precision Cancer Diagnostic Test Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 131 Europe Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
  • Figure 132 Europe Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method, 2024 & 2034 (%)
  • Figure 133 Europe Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 134 Europe Precision Cancer Diagnostic Test Market Share Forecast by End-user, 2024 & 2034 (%)
  • Figure 135 Germany Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 136 UK Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 137 France Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 138 Italy Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 139 Spain Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 140 Russia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 141 Rest of Europe Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 142 Asia Precision Cancer Diagnostic Test Market Attractiveness Index
  • Figure 143 Asia Precision Cancer Diagnostic Test Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 144 Asia Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 145 Asia Precision Cancer Diagnostic Test Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 146 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
  • Figure 147 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by Products & Services, 2024 & 2034 (%)
  • Figure 148 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
  • Figure 149 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by Test Type, 2024 & 2034 (%)
  • Figure 150 Asia Pacific Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 151 Asia Pacific Cancer Imaging Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 152 Asia Pacific Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 153 Asia Pacific Molecular Cancer Testing Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 154 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 155 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 156 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
  • Figure 157 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method, 2024 & 2034 (%)
  • Figure 158 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 159 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by End-user, 2024 & 2034 (%)
  • Figure 160 Japan Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 161 China Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 162 India Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 163 Australia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 164 South Korea Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 165 Rest of Asia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 166 Latin America Precision Cancer Diagnostic Test Market Attractiveness Index
  • Figure 167 Latin America Precision Cancer Diagnostic Test Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 168 Latin America Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 169 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 170 Latin America Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
  • Figure 171 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Products & Services, 2024 & 2034 (%)
  • Figure 172 Latin America Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
  • Figure 173 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Test Type, 2024 & 2034 (%)
  • Figure 174 Latin America Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 175 Latin America Cancer Imaging Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 176 Latin America Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
  • Figure 177 Latin America Molecular Cancer Testing Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 178 Latin America Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
  • Figure 179 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 180 Latin America Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
  • Figure 181 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method, 2024 & 2034 (%)
  • Figure 182 Latin America Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
  • Figure 183 Latin America Precision Cancer Diagnostic Test Market Share Forecast by End-user, 2024 & 2034 (%)
  • Figure 184 Brazil Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 185 Mexico Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 186 Argentina Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 187 Rest of Latin America Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 188 MEA Precision Cancer Diagnostic Test Market Attractiveness Index
  • Figure 189 MEA Precision Cancer Diagnostic Test Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 190 MEA Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
  • Figure 191 MEA Precision Cancer Diagnostic Test Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 192 MEA Precision
目次
Product Code: PHA1304

The global Precision Cancer Diagnostic Test Market is projected to grow at a CAGR of 16.1% by 2034.

“The Precision Cancer Diagnostic Test Market Report 2024-2034”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Adoption of Liquid Biopsies Propels Market Growth

The increasing adoption of liquid biopsies in cancer diagnosis has significantly intensified market competitiveness, with companies actively entering this domain viewed as key drivers of clinical advancements. LabCorp's introduction of a novel blood test in June 2023 for detecting cancer-related biomarkers exemplifies this trend, potentially expediting effective treatments. Liquid biopsy, particularly valuable for those unable to undergo tissue biopsies, is gaining traction, notably in diagnosing advanced and metastatic cancer cases. Breakthroughs, such as the detection of cancer in diverse bodily fluids through liquid biopsy in March 2022, highlight the technology's expanding applications. The ongoing development of non-invasive liquid biopsies focusing on circulating tumor DNA and other markers holds promise for transforming cancer diagnostics by enabling real-time monitoring and early detection. Industry efforts to integrate liquid biopsy with advanced AI technologies, as seen in collaborations like GC Genome Corporation with KAIST, underscore the commitment to enhancing DNA mutation analysis. Noteworthy company initiatives, including Qiagen's acquisition of Verogen and BillionToOne's precise liquid biopsy device launch, highlights the industry's focus on growth, technological advancements, and product innovation, driving market expansion.

Challenges Posed by High Cost of Precision Cancer Diagnostic Test

Precision cancer diagnostic tests utilize advanced technologies, such as next-generation sequencing (NGS) or mass spectrometry, which can be associated with high costs, posing challenges for accessibility, especially in resource-constrained regions. The elevated expenses linked to precision cancer diagnostics may act as a hindrance to market growth, restricting patient access to these advanced diagnostic tools. Despite the significant advantages offered by precision cancer diagnostics, including more accurate diagnoses and personalized treatment plans, the financial implications associated with these tests presents a formidable challenge for both healthcare systems and patients. For example, the FoundationOne CDx, priced at approximately US$5,800.0 per biopsy, delivers valuable information for treatment decisions but can impose a substantial financial burden on patients and healthcare systems. Guardant360, a liquid biopsy test by Guardant Health analyzing circulating tumor DNA, comes with a cost ranging from US$5,000 to US$6,500 per biopsy. While liquid biopsies are less invasive than tissue biopsies, their pricing remains a concern, potentially limiting access for certain patients, particularly those lacking comprehensive insurance coverage, and leading to potential delays in diagnosis and treatment decisions.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the precision cancer diagnostic test market evolving?
  • What is driving and restraining the precision cancer diagnostic test market?
  • How will each precision cancer diagnostic test submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each precision cancer diagnostic test submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading precision cancer diagnostic test markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the precision cancer diagnostic test projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of precision cancer diagnostic test projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the precision cancer diagnostic test market?
  • Where is the precision cancer diagnostic test market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the precision cancer diagnostic test market today, and over the next 10 years:

  • Our 370-page report provides 135 tables and 235 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the precision cancer diagnostic test market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising precision cancer diagnostic test prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Product & Services Outlook

  • Products
  • Services

Test Type

  • Cancer Imaging
    • Computed Tomography
    • Magnetic Resonance Imaging
    • Digital & Analog Mammography
    • Positron Emission Tomography
    • Digital Breast Tomosynthesis
    • Molecular Breast Imaging
    • Others
  • Molecular Cancer Testing
    • Polymerase Chain Reaction (PCR)
    • Next-Generation Sequencing (NGS)
    • Liquid Biopsies
    • Immunohistochemistry (IHC)
    • Fluorescence In Situ Hybridization (FISH)
    • Others
  • Tumour Marker Immunoassays
  • POC Colon Cancer Tests
  • Others

Biopsy Method

  • Liquid Biopsy
  • Tissue Biopsy

Application

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Pancreatic Cancer
  • Other Cancers

End-user

  • Diagnostic Laboratories
  • Hospitals
  • Cancer Centers and Clinics
  • Research Institutions

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Precision Cancer Diagnostic Test Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report:

  • Abbott
  • Agilent Technologies, Inc.
  • Bayer AG
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • QIAGEN N.V
  • Siemens Healthineers
  • Thermo Fisher Scientific

Overall world revenue for Precision Cancer Diagnostic Test Market, 2024 to 2034 in terms of value the market will surpass US$12,097.8 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the “Precision Cancer Diagnostic Test Market, 2024 to 2034” report help you?

In summary, our 370-page report provides you with the following knowledge:

  • Revenue forecasts to 2034 for Precision Cancer Diagnostic Test Market, 2024 to 2034 Market, with forecasts for product, test type, application, biopsy method, and end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 18 key national markets - See forecasts for the Precision Cancer Diagnostic Test Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Precision Cancer Diagnostic Test Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Precision Cancer Diagnostic Test Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Precision Cancer Diagnostic Test Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Advancements in Genomic Research
      • 3.2.1.2 High Demand for Personalized Healthcare
      • 3.2.1.3 Rising Prevalence of Cancer
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Regulatory Hurdles

3.2.2.2High Cost of Precision Cancer Diagnostic Tests

    • 3.2.3 Market Opportunities
      • 3.2.3.1 Integration of AI and Machine Learning for Cancer Diagnosis
      • 3.2.3.2 Rising Adoption of Liquid Biopsies
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis

3.4.1Bargaining Power of Suppliers

    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Precision Cancer Diagnostic Test Market Analysis by Products & Services

  • 4.1 Key Findings
  • 4.2 Product Segment: Market Attractiveness Index
  • 4.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
  • 4.4 Products
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Services
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)

5 Precision Cancer Diagnostic Test Market Analysis by Test Type

  • 5.1 Key Findings
  • 5.2 Test Type Segment: Market Attractiveness Index
  • 5.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
  • 5.4 Cancer Imaging
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.3 Computed Tomography
      • 5.4.3.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.3.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.4 Magnetic Resonance Imaging
      • 5.4.4.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.4.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.5 Digital & Analog Mammography
      • 5.4.5.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.5.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.6 Positron Emission Tomography
      • 5.4.6.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.6.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.7 Digital Breast Tomosynthesis
      • 5.4.7.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.7.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.8 Molecular Breast Imaging
      • 5.4.8.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.8.2 Market Share by Region, 2024 & 2034 (%)
    • 5.4.9 Others
      • 5.4.9.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Molecular Cancer Testing
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
    • 5.5.3 Polymerase Chain Reaction (PCR)
      • 5.5.3.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.5.3.2 Market Share by Region, 2024 & 2034 (%)
    • 5.5.4 Next-Generation Sequencing (NGS)
      • 5.5.4.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.5.4.2 Market Share by Region, 2024 & 2034 (%)
    • 5.5.5 Liquid Biopsies
      • 5.5.5.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.5.5.2 Market Share by Region, 2024 & 2034 (%)
    • 5.5.6 Immunohistochemistry (IHC)
      • 5.5.6.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.5.6.2 Market Share by Region, 2024 & 2034 (%)
    • 5.5.7 Fluorescence In Situ Hybridization (FISH)
      • 5.5.7.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.5.7.2 Market Share by Region, 2024 & 2034 (%)
    • 5.5.8 Others
      • 5.5.8.1 Market Size by Region, 2024-2034 (US$ Million)
      • 5.5.8.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Tumour Marker Immunoassays
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 POC Colon Cancer Tests
    • 5.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Others
    • 5.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Precision Cancer Diagnostic Test Market Analysis by Application

  • 6.1 Key Findings
  • 6.2 Application Segment: Market Attractiveness Index
  • 6.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
  • 6.4 Breast Cancer
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Lung Cancer
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Colorectal Cancer
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Melanoma
    • 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)
  • 6.8 Pancreatic Cancer
    • 6.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.8.2 Market Share by Region, 2024 & 2034 (%)
  • 6.9 Other Cancers
    • 6.9.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.9.2 Market Share by Region, 2024 & 2034 (%)

7 Precision Cancer Diagnostic Test Market Analysis by Biopsy Method

  • 7.1 Key Findings
  • 7.2 Biopsy Method Segment: Market Attractiveness Index
  • 7.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
  • 7.4 Liquid Biopsy
    • 7.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 Tissue Biopsy
    • 7.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)

8 Precision Cancer Diagnostic Test Market Analysis by End-user

  • 8.1 Key Findings
  • 8.2 End-users Segment: Market Attractiveness Index
  • 8.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
  • 8.4 Diagnostic Laboratories
    • 8.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.4.2 Market Share by Region, 2024 & 2034 (%)
  • 8.5 Hospitals
    • 8.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.5.2 Market Share by Region, 2024 & 2034 (%)
  • 8.6 Cancer Centers and Clinics
    • 8.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.6.2 Market Share by Region, 2024 & 2034 (%)
  • 8.7 Research Institutions
    • 8.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.7.2 Market Share by Region, 2024 & 2034 (%)

9 Precision Cancer Diagnostic Test Market Analysis by Region

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast

10 North America Precision Cancer Diagnostic Test Market Analysis

  • 10.1 Key Findings
  • 10.2 North America Precision Cancer Diagnostic Test Market Attractiveness Index
  • 10.3 North America Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 10.4 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
  • 10.5 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
  • 10.6 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
    • 10.6.1 North America Cancer Imaging Market Size Estimation and Forecast by Type
    • 10.6.2 North America Molecular Cancer Testing Market Size Estimation and Forecast by Type
  • 10.7 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
  • 10.8 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
  • 10.9 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
  • 10.10 U.S. Precision Cancer Diagnostic Test Market Analysis
  • 10.11 Canada Precision Cancer Diagnostic Test Market Analysis

11 Europe Precision Cancer Diagnostic Test Market Analysis

  • 11.1 Key Findings
  • 11.2 Europe Precision Cancer Diagnostic Test Market Attractiveness Index
  • 11.3 Europe Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 11.4 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
  • 11.5 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
  • 11.6 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
    • 11.6.1 Europe Cancer Imaging Market Size Estimation and Forecast by Type
    • 11.6.2 Europe Molecular Cancer Testing Market Size Estimation and Forecast by Type
  • 11.7 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
  • 11.8 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
  • 11.9 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
  • 11.10 Germany Precision Cancer Diagnostic Test Market Analysis
  • 11.11 UK Precision Cancer Diagnostic Test Market Analysis
  • 11.12 France Precision Cancer Diagnostic Test Market Analysis
  • 11.13 Italy Precision Cancer Diagnostic Test Market Analysis
  • 11.14 Spain Precision Cancer Diagnostic Test Market Analysis
  • 11.15 Russia Precision Cancer Diagnostic Test Market Analysis
  • 11.16 Rest of Europe Precision Cancer Diagnostic Test Market Analysis

12 Asia Precision Cancer Diagnostic Test Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Precision Cancer Diagnostic Test Market Attractiveness Index
  • 12.3 Asia Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 12.4 Asia Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
  • 12.5 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
  • 12.6 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
    • 12.6.1 Asia Pacific Cancer Imaging Market Size Estimation and Forecast by Type
    • 12.6.2 Asia Pacific Molecular Cancer Testing Market Size Estimation and Forecast by Type
  • 12.7 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
  • 12.8 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
  • 12.9 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user

12.10Japan Precision Cancer Diagnostic Test Market Analysis

12.11China Precision Cancer Diagnostic Test Market Analysis

12.12India Precision Cancer Diagnostic Test Market Analysis

12.13Australia Precision Cancer Diagnostic Test Market Analysis

12.14South Korea Precision Cancer Diagnostic Test Market Analysis

12.15Rest of Asia Precision Cancer Diagnostic Test Market Analysis

13 Latin America Precision Cancer Diagnostic Test Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Precision Cancer Diagnostic Test Market Attractiveness Index
  • 13.3 Latin America Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 13.4 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
  • 13.5 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
  • 13.6 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
    • 13.6.1 Latin America Cancer Imaging Market Size Estimation and Forecast by Type
    • 13.6.2 Latin America Molecular Cancer Testing Market Size Estimation and Forecast by Type
  • 13.7 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
  • 13.8 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
  • 13.9 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user

13.10Brazil Precision Cancer Diagnostic Test Market Analysis

13.11Mexico Precision Cancer Diagnostic Test Market Analysis

13.12Argentina Precision Cancer Diagnostic Test Market Analysis

13.13Rest of Latin America Precision Cancer Diagnostic Test Market Analysis

14 MEA Precision Cancer Diagnostic Test Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Precision Cancer Diagnostic Test Market Attractiveness Index
  • 14.3 MEA Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 14.4 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
  • 14.5 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
  • 14.6 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
    • 14.6.1 MEA Cancer Imaging Market Size Estimation and Forecast by Type
    • 14.6.2 MEA Molecular Cancer Testing Market Size Estimation and Forecast by Type
  • 14.7 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
  • 14.8 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
  • 14.9 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
  • 14.10 GCC Precision Cancer Diagnostic Test Market Analysis
  • 14.11 South Africa Precision Cancer Diagnostic Test Market Analysis
  • 14.12 Rest of MEA Precision Cancer Diagnostic Test Market Analysis

15 Company Profiles

  • 15.1 Company Share Analysis, 2023
  • 15.2 Strategic Outlook
  • 15.3 F. Hoffmann-La Roche Ltd.
    • 15.3.1 Company Snapshot
    • 15.3.2 Company Overview
    • 15.3.3 Financial Analysis
      • 15.3.3.1 Net Revenue, 2017-2022
      • 15.3.3.2 R&D, 2017-2022
    • 15.3.4 Product Benchmarking
    • 15.3.5 Strategic Outlook
  • 15.4 Illumina, Inc.
    • 15.4.1 Company Snapshot
    • 15.4.2 Company Overview
    • 15.4.3 Financial Analysis
      • 15.4.3.1 Net Revenue, 2017-2022
      • 15.4.3.2 R&D, 2017-2022
      • 15.4.3.3 Regional Market Shares, 2022
    • 15.4.4 Product Benchmarking
    • 15.4.5 Strategic Outlook
  • 15.5 Abbott
    • 15.5.1 Company Snapshot
    • 15.5.2 Company Overview
    • 15.5.3 Financial Analysis
      • 15.5.3.1 Net Revenue, 2017-2022
      • 15.5.3.2 R&D, 2017-2022
      • 15.5.3.3 Regional Market Shares, 2022
    • 15.5.4 Product Benchmarking
    • 15.5.5 Strategic Outlook
  • 15.6 QIAGEN N.V.
    • 15.6.1 Company Snapshot
    • 15.6.2 Company Overview
    • 15.6.3 Financial Analysis
      • 15.6.3.1 Net Revenue, 2017-2022
      • 15.6.3.2 R&D, 2017-2022
    • 15.6.4 Product Benchmarking
    • 15.6.5 Strategic Outlook
  • 15.7 Thermo Fisher Scientific
    • 15.7.1 Company Snapshot
    • 15.7.2 Company Overview
    • 15.7.3 Financial Analysis
      • 15.7.3.1 Net Revenue, 2017-2022
      • 15.7.3.2 R&D, 2017-2022
      • 15.7.3.3 Regional Market Shares, 2022
    • 15.7.4 Product Benchmarking
    • 15.7.5 Strategic Outlook
  • 15.8 bioMerieux SA
    • 15.8.1 Company Snapshot
    • 15.8.2 Company Overview
    • 15.8.3 Financial Analysis
      • 15.8.3.1 Net Revenue, 2017-2022
      • 15.8.3.2 R&D, 2017-2022
      • 15.8.3.3 Regional Market Shares, 2022
    • 15.8.4 Product Benchmarking
  • 15.9 Siemens Healthineers
    • 15.9.1 Company Snapshot
    • 15.9.2 Company Overview
    • 15.9.3 Financial Analysis
      • 15.9.3.1 Net Revenue, 2017-2022
      • 15.9.3.2 R&D, 2017-2022
    • 15.9.4 Product Benchmarking
    • 15.9.5 Strategic Outlook
  • 15.10 Bayer AG
    • 15.10.1 Company Snapshot
    • 15.10.2 Company Overview
    • 15.10.3 Financial Analysis
      • 15.10.3.1 Net Revenue, 2017-2022
      • 15.10.3.2 R&D, 2017-2022
      • 15.10.3.3 Regional Market Shares, 2022
    • 15.10.4 Product Benchmarking
    • 15.10.5 Strategic Outlook
  • 15.11 Myriad Genetics, Inc.
    • 15.11.1 Company Snapshot
    • 15.11.2 Company Overview
    • 15.11.3 Financial Analysis
      • 15.11.3.1 Net Revenue, 2017-2022
      • 15.11.3.2 R&D, 2017-2022
    • 15.11.4 Product Benchmarking
    • 15.11.5 Strategic Outlook
  • 15.12 Agilent Technologies, Inc.
    • 15.12.1 Company Snapshot
    • 15.12.2 Company Overview
    • 15.12.3 Financial Analysis
      • 15.12.3.1 Net Revenue, 2017-2022
      • 15.12.3.2 R&D, 2017-2022
      • 15.12.3.3 Regional Market Shares, 2022
    • 15.12.4 Product Benchmarking
    • 15.12.5 Strategic Outlook

16 Conclusion and Recommendations

  • 16.1 Concluding Remarks from Visiongain
  • 16.2 Recommendations for Market Players